Related content

Mitiglinide/voglibose fixed-dose combination improves postprandial glycemic excursions in Japanese patients with type 2 diabetes mellitus

By Ono Yuri   Kameda Hiraku   Cho Kyu Yong  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 4, 2013-03 ,pp. : 361-370

Informa Healthcare

Access to resources Recommend Favorite

Tighter control of postprandial hyperglycemia with mitiglinide/voglibose fixed-dose combination in Japanese patients with type 2 diabetes mellitus

By Inoue Masahiro  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 16, 2012-11 ,pp. : 2257-2268

Informa Healthcare

Access to resources Recommend Favorite

Comparison of the hypoglycemic effect of sitagliptin versus the combination of mitiglinide and voglibose in drug-naïve Japanese patients with type 2 diabetes

By Ohta Akio   Ohshige Toshihiko   Sakai Kensuke   Nakamura Yuta   Tenjin Ayumi   Tsukiyama Shuichi   Terashima Yuko   Matsubara Fumiaki   Kawata Takehiro   Nagai Yoshio   Tanaka Yasushi  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 17, 2013-12 ,pp. : 2315-2322

Informa Healthcare

Access to resources Recommend Favorite

Liraglutide has demonstrated efficacy as an add-on therapy for type 2 diabetes mellitus

By  

Inpharma, Vol. 1, Iss. 1608, 2007-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Pharmacological profile, efficacy and safety of lixisenatide in type 2 diabetes mellitus

By Forst Thomas   Pfützner Andreas  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 16, 2013-11 ,pp. : 2281-2296

Informa Healthcare

Access to resources Recommend Favorite